These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7060343)

  • 1. [Indications for the use of phosphocreatine in cardiology].
    Pinelli G; Di Pasquale G; Alberici S; Manini G; Coluccini M
    Clin Ter; 1982 Feb; 100(3):261-79. PubMed ID: 7060343
    [No Abstract]   [Full Text] [Related]  

  • 2. [Polygraphic and electrocardiographic study of a new coronary therapeutic agent: dilazep].
    Parenti B; Selvaggi R
    Clin Ter; 1980 Jan; 92(2):155-63. PubMed ID: 7389275
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronoinotropic reserves of the myocardium.
    Churin VD
    Hum Physiol; 1978; 4(3):318-22. PubMed ID: 753705
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of nifedipine on exercise tolerance and cardiac mechanics, evaluated with systolic time].
    Tomei G; Mosti G; Veltri M; Giusti C
    Boll Soc Ital Cardiol; 1977; 22(4):475-84. PubMed ID: 617295
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiovascular effects of nifedipine--a 4-week treatment in preselected patients with coronary disease.
    Słomińska-Petelenz T; Petelenz T; Chruściel TL; Wilk J; Elertowicz M; Axenti I
    Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):122-7. PubMed ID: 7068285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of kinilentin on phase structure of left ventricular systole and hemodynamic parameters].
    Pashchenko LS; Zapevina VV; Poliakova LA; Nikolaeva SA
    Sov Med; 1989; (12):125-6. PubMed ID: 2631239
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of digoxin on myocardial oxygen consumption in coronary heart disease].
    Tauchert M; Behrenbeck DW; Hötzel J; Jansen W; Niehues B; Hilger HH
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1641-4. PubMed ID: 611899
    [No Abstract]   [Full Text] [Related]  

  • 8. [Exogenous phosphocreatine in the prevention and treatment of cardiac insufficiency in patients with myocardial infarction].
    Perepech NB; Nedoshivin AO; Kutuzova AE
    Klin Med (Mosk); 1993 Jan; 71(1):19-22. PubMed ID: 8046897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the hemodynamic effects of acute infusion and short-term treatment with creatine phosphate].
    Acito P; Busi F; Moscatelli G; Riva P
    Clin Ter; 1984 Dec; 111(5):427-33. PubMed ID: 6240369
    [No Abstract]   [Full Text] [Related]  

  • 10. [Phosphocreatine in ischemic cardiopathy].
    Caporicci D; Giunti M; Mariotti W; Brun M; Rongoni R; Maria A; Dormi A
    Clin Ter; 1987 Aug; 122(4):257-62. PubMed ID: 2973386
    [No Abstract]   [Full Text] [Related]  

  • 11. Oxyfedrine and cardiac inotropism in coronary artery disease.
    Krishnaswami S; Sathyamurthy I; Mao R; Padmakumar P
    Indian Heart J; 1984; 36(3):161-5. PubMed ID: 6490047
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of sodium oxybutyrate on the blood supply and activity of the normal and ischemic myocardium].
    Chichkanov GG; Bogolepov AK; Tsorin IB; Matsievskiĭ DD
    Biull Eksp Biol Med; 1982 Mar; 93(3):44-7. PubMed ID: 7093482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of phosphocreatine on the blood supply of the ischemic myocardium].
    Kryzhanovskiĭ SA; Kandelaki IN; Kaverina NV; Vititnova MB; Saks VA
    Fiziol Zh (1978); 1988; 34(4):84-6. PubMed ID: 3181516
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acebutolol in the treatment of coronary disease - ergometric and polycardiographic studies and evaluation of liver metabolism].
    Goch JH; Adamska-Dyniewska H; Pruszczyński J; Trela R
    Pol Tyg Lek; 1983 Jan; 38(3):91-4. PubMed ID: 6866827
    [No Abstract]   [Full Text] [Related]  

  • 15. The post two-step electrocardiogram and hemodynamic determinants of myocardial oxygen consumption.
    Makous N; Gittleman MA; Valbuena Atencio NE
    Mal Cardiovasc; 1969; 10(1):161-82. PubMed ID: 5378956
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of intencordin on the phase structure of the systole of left ventricle and amino acid content of blood serum in ischemic heart disease].
    Todosienko LA
    Vrach Delo; 1979 Jan; (1):16-21. PubMed ID: 425457
    [No Abstract]   [Full Text] [Related]  

  • 17. [Importance of electrocardiographic tests with physical loading for vital prognosis in ischemic heart disease].
    Lupanov VP
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981; 4(1):110-5. PubMed ID: 7020719
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cardiodynamic changes induced with dilazep in chronic coronary insufficiency].
    Fogari R
    G Ital Cardiol; 1980; 10(12):1675-8. PubMed ID: 7250592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between the cycloergometric exercise test and acute infusion of intravenous dipyridamole].
    Ziletti G; Emanuelli C; Manzetti G; Ricevuti A; Bonifazi C; Distante S
    Boll Soc Ital Cardiol; 1981; 26(12):2051-60. PubMed ID: 7185373
    [No Abstract]   [Full Text] [Related]  

  • 20. [Morphologic and biochemical criteria of the efficacy of clinical use of phosphocreatine (neoton) for intraoperative protection of the myocardium].
    Chazov EI; Semenovskiĭ ML; Smirnov VN; Shumakov VI; Saks VA
    Fiziol Zh (1978); 1986; 32(1):3-13. PubMed ID: 3956779
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.